YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2

Abstract Background Ginkgo biloba has been reported to possess free radical-scavenging antioxidant activity and anti-inflammatory properties. In our pilot study, YY-1224, a terpene trilactone-strengthened extract of G. biloba, showed anti-inflammatory, neurotrophic, and antioxidant effects. Results...

Full description

Bibliographic Details
Main Authors: Zheng-Yi Li, Yoon Hee Chung, Eun-Joo Shin, Duy-Khanh Dang, Ji Hoon Jeong, Sung Kwon Ko, Seung-Yeol Nah, Tae Gon Baik, Jin Hyeong Jhoo, Wei-Yi Ong, Toshitaka Nabeshima, Hyoung-Chun Kim
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-017-0866-x
_version_ 1828292935174586368
author Zheng-Yi Li
Yoon Hee Chung
Eun-Joo Shin
Duy-Khanh Dang
Ji Hoon Jeong
Sung Kwon Ko
Seung-Yeol Nah
Tae Gon Baik
Jin Hyeong Jhoo
Wei-Yi Ong
Toshitaka Nabeshima
Hyoung-Chun Kim
author_facet Zheng-Yi Li
Yoon Hee Chung
Eun-Joo Shin
Duy-Khanh Dang
Ji Hoon Jeong
Sung Kwon Ko
Seung-Yeol Nah
Tae Gon Baik
Jin Hyeong Jhoo
Wei-Yi Ong
Toshitaka Nabeshima
Hyoung-Chun Kim
author_sort Zheng-Yi Li
collection DOAJ
description Abstract Background Ginkgo biloba has been reported to possess free radical-scavenging antioxidant activity and anti-inflammatory properties. In our pilot study, YY-1224, a terpene trilactone-strengthened extract of G. biloba, showed anti-inflammatory, neurotrophic, and antioxidant effects. Results We investigated the pharmacological potential of YY-1224 in β-amyloid (Aβ) (1-42)-induced memory impairment using cyclooxygenase-2 (COX-2) knockout (−/−) and APPswe/PS1dE9 transgenic (APP/PS1 Tg) mice. Repeated treatment with YY-1224 significantly attenuated Aβ (1-42)-induced memory impairment in COX-2 (+/+) mice, but not in COX-2 (−/−) mice. YY-1224 significantly attenuated Aβ (1-42)-induced upregulation of platelet-activating factor (PAF) receptor gene expression, reactive oxygen species, and pro-inflammatory factors. In addition, YY-1224 significantly inhibited Aβ (1-42)-induced downregulation of PAF-acetylhydrolase-1 (PAF-AH-1) and peroxisome proliferator-activated receptor γ (PPARγ) gene expression. These changes were more pronounced in COX-2 (+/+) mice than in COX-2 (−/−) mice. YY-1224 significantly attenuated learning impairment, Aβ deposition, and pro-inflammatory microglial activation in APP/PS1 Tg mice, whereas it significantly enhanced PAF-AH and PPARγ expression. A preferential COX-2 inhibitor, meloxicam, did not affect the pharmacological activity by YY-1224, suggesting that the COX-2 gene is a critical mediator of the neuroprotective effects of YY-1224. The protective activity of YY-1224 appeared to be more efficacious than a standard G. biloba extract (Gb) against Aβ insult. Conclusions Our results suggest that the protective effects of YY-1224 against Aβ toxicity may be associated with its PAF antagonistic- and PPARγ agonistic-potential as well as inhibition of the Aβ-mediated pro-inflammatory switch of microglia phenotypes through suppression of COX-2 expression.
first_indexed 2024-04-13T11:16:37Z
format Article
id doaj.art-6867afb289db48a4b826cd2bd941df8e
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-04-13T11:16:37Z
publishDate 2017-04-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-6867afb289db48a4b826cd2bd941df8e2022-12-22T02:48:57ZengBMCJournal of Neuroinflammation1742-20942017-04-0114112210.1186/s12974-017-0866-xYY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2Zheng-Yi Li0Yoon Hee Chung1Eun-Joo Shin2Duy-Khanh Dang3Ji Hoon Jeong4Sung Kwon Ko5Seung-Yeol Nah6Tae Gon Baik7Jin Hyeong Jhoo8Wei-Yi Ong9Toshitaka Nabeshima10Hyoung-Chun Kim11Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National UniversityDepartment of Anatomy, College of Medicine, Chung-Ang UniversityNeuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National UniversityNeuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National UniversityDepartment of Pharmacology, College of Medicine, Chung-Ang UniversityDepartment of Oriental Medical Food and Nutrition, Semyung UniversityGinsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine and Bio/Molecular Informatics Center, Konkuk UniversityR&D Center, Yuyu PharmaDepartment of Psychiatry, Medical School, Kangwon National UniversityDepartment of Anatomy, National University of SingaporeNabeshima Laboratory, Graduate School of Pharmaceutical Sciences, Meijo UniversityNeuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National UniversityAbstract Background Ginkgo biloba has been reported to possess free radical-scavenging antioxidant activity and anti-inflammatory properties. In our pilot study, YY-1224, a terpene trilactone-strengthened extract of G. biloba, showed anti-inflammatory, neurotrophic, and antioxidant effects. Results We investigated the pharmacological potential of YY-1224 in β-amyloid (Aβ) (1-42)-induced memory impairment using cyclooxygenase-2 (COX-2) knockout (−/−) and APPswe/PS1dE9 transgenic (APP/PS1 Tg) mice. Repeated treatment with YY-1224 significantly attenuated Aβ (1-42)-induced memory impairment in COX-2 (+/+) mice, but not in COX-2 (−/−) mice. YY-1224 significantly attenuated Aβ (1-42)-induced upregulation of platelet-activating factor (PAF) receptor gene expression, reactive oxygen species, and pro-inflammatory factors. In addition, YY-1224 significantly inhibited Aβ (1-42)-induced downregulation of PAF-acetylhydrolase-1 (PAF-AH-1) and peroxisome proliferator-activated receptor γ (PPARγ) gene expression. These changes were more pronounced in COX-2 (+/+) mice than in COX-2 (−/−) mice. YY-1224 significantly attenuated learning impairment, Aβ deposition, and pro-inflammatory microglial activation in APP/PS1 Tg mice, whereas it significantly enhanced PAF-AH and PPARγ expression. A preferential COX-2 inhibitor, meloxicam, did not affect the pharmacological activity by YY-1224, suggesting that the COX-2 gene is a critical mediator of the neuroprotective effects of YY-1224. The protective activity of YY-1224 appeared to be more efficacious than a standard G. biloba extract (Gb) against Aβ insult. Conclusions Our results suggest that the protective effects of YY-1224 against Aβ toxicity may be associated with its PAF antagonistic- and PPARγ agonistic-potential as well as inhibition of the Aβ-mediated pro-inflammatory switch of microglia phenotypes through suppression of COX-2 expression.http://link.springer.com/article/10.1186/s12974-017-0866-xTerpene trilactone-strengthened G. bilobaPlatelet-activating factorPeroxisome proliferators-activated receptor γMicrogliaAPPswe/PS1dE9 transgenic miceCyclooxygenase-2 knockout mice
spellingShingle Zheng-Yi Li
Yoon Hee Chung
Eun-Joo Shin
Duy-Khanh Dang
Ji Hoon Jeong
Sung Kwon Ko
Seung-Yeol Nah
Tae Gon Baik
Jin Hyeong Jhoo
Wei-Yi Ong
Toshitaka Nabeshima
Hyoung-Chun Kim
YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
Journal of Neuroinflammation
Terpene trilactone-strengthened G. biloba
Platelet-activating factor
Peroxisome proliferators-activated receptor γ
Microglia
APPswe/PS1dE9 transgenic mice
Cyclooxygenase-2 knockout mice
title YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
title_full YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
title_fullStr YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
title_full_unstemmed YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
title_short YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2
title_sort yy 1224 a terpene trilactone strengthened ginkgo biloba attenuates neurodegenerative changes induced by β amyloid 1 42 or double transgenic overexpression of app and ps1 via inhibition of cyclooxygenase 2
topic Terpene trilactone-strengthened G. biloba
Platelet-activating factor
Peroxisome proliferators-activated receptor γ
Microglia
APPswe/PS1dE9 transgenic mice
Cyclooxygenase-2 knockout mice
url http://link.springer.com/article/10.1186/s12974-017-0866-x
work_keys_str_mv AT zhengyili yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT yoonheechung yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT eunjooshin yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT duykhanhdang yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT jihoonjeong yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT sungkwonko yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT seungyeolnah yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT taegonbaik yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT jinhyeongjhoo yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT weiyiong yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT toshitakanabeshima yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2
AT hyoungchunkim yy1224aterpenetrilactonestrengthenedginkgobilobaattenuatesneurodegenerativechangesinducedbybamyloid142ordoubletransgenicoverexpressionofappandps1viainhibitionofcyclooxygenase2